DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Cannabinoids for Taxane Induced Peripheral Neuropathy

Phase 2

Terminated

Conditions: Chemotherapy-induced Peripheral Neuropathy

Interventions: Drug: Cannabinoids

First Posted Date: 2018-12-20

Last Posted Date: 2023-01-26

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 12

Registration Number: NCT03782402

Locations: 🇺🇸
1051 Riverside Drive, New York, New York, United States

Influence of Tobacco Use on Cannabis Use

Phase 2

Suspended

Conditions: Tobacco Use
Cannabis Use

Interventions: Behavioral: 7 days of Tobacco Cessation
Behavioral: 21 days of Tobacco Cessation
Drug: Cannabis

First Posted Date: 2018-12-06

Last Posted Date: 2024-08-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 160

Registration Number: NCT03766971

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

Phase 4

Terminated

Conditions: Dysthymia
Depression
Major Depressive Disorder

Interventions: Drug: Placebo Oral Tablet
Drug: L-DOPA

First Posted Date: 2018-12-03

Last Posted Date: 2023-05-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 51

Registration Number: NCT03761030

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

D-serine Augmentation of Neuroplasticity

Phase 1

Completed

Conditions: Schizophrenia
Schizo Affective Disorder

Interventions: Drug: D-serine
Drug: Placebo

First Posted Date: 2018-10-18

Last Posted Date: 2022-06-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 45

Registration Number: NCT03711500

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸
Nathan Kline Institute, Orangeburg, New York, United States

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Phase 3

Terminated

Conditions: Heroin Dependence

Interventions: Drug: Buprenorphine/naloxone

First Posted Date: 2018-10-18

Last Posted Date: 2022-12-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 8

Registration Number: NCT03711318

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia

Phase 1

Completed

Conditions: Pain
Abuse, Drug

Interventions: Drug: Placebo
Drug: Oxycodone

First Posted Date: 2018-09-21

Last Posted Date: 2024-12-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 26

Registration Number: NCT03679949

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

Not Applicable

Completed

Conditions: Alcohol Use Disorder
Binge Drinking
HIV/AIDS
Hepatitis C

First Posted Date: 2018-08-29

Last Posted Date: 2021-07-23

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 31

Registration Number: NCT03652675

Locations: 🇺🇸
NewYork-Presbyterian / Columbia University Medical Center, New York, New York, United States

Lorcaserin for Cannabis Use Disorder

Early Phase 1

Terminated

Conditions: Cannabis Use Disorder

Interventions: Drug: Lorcaserin
Drug: Placebo oral capsule

First Posted Date: 2018-08-20

Last Posted Date: 2021-01-28

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 5

Registration Number: NCT03637842

Locations: 🇺🇸
Columbia Substance Treatment and Research Service, New York, New York, United States

Adapting Critical Time Intervention to Support Inpatient Medical Care Transition

Not Applicable

Terminated

Conditions: Medical Complication
Schizophrenia

Interventions: Other: Critical time intervention

First Posted Date: 2018-08-17

Last Posted Date: 2021-09-28

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 15

Registration Number: NCT03637296

Locations: 🇺🇸
Bronx Care Health System, Bronx, New York, United States
🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Training Providers to Conduct PRIDES-sSA

Not Applicable

Recruiting

Conditions: Severe Mental Disorder
Common Mental Disorders

Interventions: Other: psychiatric medications and evidence-based psychotherapies

First Posted Date: 2018-08-01

Last Posted Date: 2024-05-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 901

Registration Number: NCT03610750

Locations: 🇲🇿
MIHER: Mozambique Institute for Health Education and Research, Maputo, Mozambique

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy